4:51 PM
Jan 27, 2014
 |  BC Extra  |  Company News

FDA reviewing Medac's injectable methotrexate

FDA accepted an NDA from Medac GmbH (Wedel, Germany) for MPI-2505 -- an autopen containing subcutaneous injectable methotrexate -- to treat...

Read the full 92 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >